Human in Motion's XoMotion is a self-balancing robotic exoskeleton; XoMotion-R is positioned for supervised lower-extremity rehabilitation. Adjustable fitting, sensing and control support clinical sessions and robotics research.
Technical detail
Core features
Self-balancing control with sensors and multimodal controllers
Adjustable fit and hot-swappable batteries
Research access to motion control and sensor data
Exoskeleton
Rehabilitation-robotics
Use & integration
Recorded applications
Neurological and mobility rehabilitation
Human-assistive robotics research and training
These describe the reviewed application scope, not confirmed deployments, released requirements or procurement eligibility.
Evidence of maturity
The manufacturer announced its first XoMotion-R sale to Synaptic Health in February 2025. The current site distinguishes rehabilitation availability from future personal-use versions and states that XoMotion is not yet FDA-cleared.
Commercial availability
Canadian rehabilitation and research facilities can enquire about acquisition; investigators can discuss research access. Eligibility and clinical use must be checked for the intended jurisdiction and setting.
Integration and verification
Readiness
A technology readiness level is not established by the reviewed public sources.
Reviewed connections
No reviewed Mission area or released Defence need connection is currently published.
Original sources 3 linked records
These records support this capability and its published Mission area and Defence need connections. A source count is not a count of independent confirmations.
XoMotion combines powered joints, balance control, sensing, and multimodal gait control to assist standing and locomotion without relying on crutches. Regulatory clearance and clinical availability vary by jurisdiction and require verification.
Supports: Capability · name
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · core features
Self-balancing hands-free exoskeleton
Supports: Capability · technicaldomainslugs
True North Map maps XoMotion robotic exoskeleton to autonomous systems from its documented technology functions.
Supports: Capability · technical tags
True North Map applies the rehabilitation-robotics tag from Human in Motion Robotics's documented capability functions.
Supports: Capability · core features
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · commercial availability
Human in Motion Robotics currently presents XoMotion robotic exoskeleton through its official public capability surface.
Supports: Capability · capability type
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · technicaldomainslugs
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · maturity
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · capability type
Source-bounded strategic technology capability
Supports: Capability · defence applications
Neurological and mobility rehabilitation
Supports: Capability · technical tags
True North Map applies the exoskeleton tag from Human in Motion Robotics's documented capability functions.
Supports: Capability · technical tags
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · technical tags
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · defence applications
Human-assistive robotics research and training
Supports: Capability · summary
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · defence applications
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · core features
Complex-gait control with onboard sensing
Supports: Capability · name
XoMotion robotic exoskeleton This bounded statement is retained for reviewer verification.
Supports: Capability · core features
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · core features
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Supports: Capability · defence applications
XoMotion is a self-balancing robotic exoskeleton for lower-extremity motor deficits, with XoMotion-R positioned for supervised spinal-cord-injury rehabilitation. The platform combines sensors and multimodal controllers, adjustable fitting, hot-swappable batteries and research access to motion and sensor data. The official site distinguishes rehabilitation-centre XoMotion-R availability from future broader-neurology and personal-use versions. Clinical specialists and research teams can enquire about XoMotion; an open control platform is available to investigators. Human in Motion Robotics is headquartered in Vancouver with an APAC office in Seoul. The current official XoMotion page expressly states that it is not yet FDA-cleared.
Pacific Economic Development Canada's public evidence confirms a company-specific project, award, program or operating context, while configuration-specific acceptance and scale remain bounded by the reviewer warning.
Human in Motion announced the first XoMotion-R sale to Synaptic Health in Calgary in February 2025 for rehabilitation use; the release is issued by the manufacturer. The manufacturer offers acquisition by Canadian rehabilitation and research facilities and research access internationally; establishment licensing is not evidence of device approval for every jurisdiction.
Supports: Capability · technology readiness level
Human in Motion announced the first XoMotion-R sale to Synaptic Health in Calgary in February 2025 for rehabilitation use; the release is issued by the manufacturer. The manufacturer offers acquisition by Canadian rehabilitation and research facilities and research access internationally; establishment licensing is not evidence of device approval for every jurisdiction.
Public sources cited · Facts and assessments kept separate · Human review
Human in Motion announced the first XoMotion-R sale to Synaptic Health in Calgary in February 2025 for rehabilitation use; the release is issued by the manufacturer. The manufacturer offers acquisition by Canadian rehabilitation and research facilities and research access internationally; establishment licensing is not evidence of device approval for every jurisdiction.